Skip to content

Combinations of serum multiplex autoantibodies combine with LDCT in early diagnosis of lung cancer

Combinations of serum multiplex autoantibodies combine with LDCT in early diagnosis of lung cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDD-17010378
Enrollment
Unknown
Registered
2017-01-11
Start date
2017-01-15
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

early-stage lung cancer

Interventions

Sponsors

the Fourth Affiliated Hospital of Guangxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. between 55 and 74 years of age at the time of randomization, had a history of cigarette smoking of at least 30 pack-years, and, if former smokers, had quit within the previous 15 years; 2. Persons are =40 years of age and had a history of cigarette smoking of at least 20 pack-years,and at least had an extra risk factor (previously re-ceived a diagnosis of lung cancer, history of pulmonary diseases, family history of lung cancer or occupational exposure)

Exclusion criteria

Exclusion criteria: 1. Healthy population <40 years; 2. Persons that can't meet the follow-up

Design outcomes

Primary

MeasureTime frame
Positive rate of early diagnosis of lung cancer;Sensitivity of TAABs;Specitivity of TAABs;

Countries

China

Contacts

Public ContactZhou-Gui Ling

the Fourth Affiliated Hospital of Guangxi Medical University

lzg228@163.com+86 13877217374

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026